Against this backdrop, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), first used for type 2 diabetes, have emerged as potent weight-loss agents with possible anti-inflammatory actions, making them attractive candidates in HS care
10.1016/b978-0-12-801022-8.00011-8 Int
Over the course of the study, 26% of GLP-1 users stopped taking the medication and about 23% had an interruption of six months or more followed by resuming treatment
Just keep in mind lemon can irritate sensitive skin, so its best used cautiously and always followed by sunscreen
Estimation of direct healthcare costs of fungal diseases in the United States
As the saying goes, there appears to be a there there. Its important that we continue to intentionally study the short and long-term outcomes of use of these meds explicitly in those at risk for and developing early stage Alzheimers disease and related dementias, he advised